Pureos Bioventures
Pureos Bioventures is a new venture capital fund
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Pureos Bioventures Information
Geographic Data
Address: Seestrasse 16
City: Kusnacht
State: zurich
Zip: 8700
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$205M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Pureos Bioventures is a new venture capital fund located in Zurich to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2020 | ImCheck Therapeutics | Series B | 0 |
| 6/2021 | Alentis Therapeutics | Series B | 66.8M |
| 3/2023 | Mediar Therapeutics | Series A | 0 |
| 10/2020 | Araris Biotech | Seed Round | 0 |
| 4/2023 | Alentis Therapeutics | Series C | 0 |
| 9/2022 | Tridek-One | Venture Round | 0 |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 3/2019 | NovaGo Therapeutics | Series A | 0 |
| 7/2019 | AM Pharma | Series F | 130.1M |
| 6/2022 | Ariceum Therapeutics | Series A | 0 |
| 11/2020 | Corlieve Therapeutics | Seed Round | - |
| 4/2023 | Ariceum Therapeutics | Series A | 0 |
| 5/2022 | Engimmune Therapeutics | Seed Round | 15.8M |
| 12/2022 | Minervax | Series C | 0 |
| 1/2020 | Eyevensys | Series B | 30M |
| 11/2021 | Acrivon Therapeutics | Series B | 0 |
| 10/2022 | Araris Biotech | Series A | 24M |
| 5/2021 | Hummingbird Bioscience | Series C | 0 |
| 9/2020 | Lava Therapeutics | Series C | 83M |
| 7/2020 | Vico Therapeutics | Series A | 31M |
| 4/2019 | Alentis Therapeutics | Series A | 12.3M |
| 6/2022 | ImCheck Therapeutics | Series C | 0 |
| 6/2022 | Ariceum Therapeutics | Series A | 0 |
| 5/2022 | Engimmune Therapeutics | Seed Round | 0 |
| 11/2021 | Acrivon Therapeutics | Series B | 0 |
| 6/2021 | Alentis Therapeutics | Series B | 0 |
| 5/2021 | Hummingbird Bioscience | Series C | 0 |
| 11/2020 | Corlieve Therapeutics | Seed Round | - |
| 10/2020 | Araris Biotech | Seed Round | 0 |
| 9/2020 | Lava Therapeutics | Series C | 0 |
| 9/2020 | ImCheck Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
